Biomarkers & Hypersensitivity Pneumonitis Progression Request More Information Trial Objective Researchers are studying the blood of hypersensitivity pneumonitis (HP) patients to find out if biomarkers found can predict the progression of the disease. Researchers are particularly interested in understanding if the biomarkers in blood can predict the speed of disease progression. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate Adults 18 years of age and older. Age: 18-80 Gender: Any Gender Estimated Time Commitment Not Specified × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Not Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Elizabeth Del Real 303.398.1172 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors National Institutes of Health Principal Investigators Evans Fernández, MD, MS + × Evans Fernández, MD, MS Associate Professor Division of Pulmonary, Critical Care & Sleep Medicine Department of Medicine View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Co-Investigators Joshua Solomon, MD + × Joshua Solomon, MD Director, Interstitial Lung Disease Program Associate Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine Section of Critical Care Medicine View Full Profile Patient Rating 4.8 out of 5 stars Make an Appoinment Michael Mohning, MD + × Michael Mohning, MD Assistant Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine Interstitial Lung Disease Program View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Rebecca Keith, MD + × Rebecca Keith, MD Associate Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine Interstitial Lung Disease Program Autoimmune Lung Center View Full Profile Patient Rating 4.5 out of 5 stars Make an Appoinment Zulma Yunt, MD + × Zulma Yunt, MD Assistant Professor of Medicine Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine View Full Profile Patient Rating 4.7 out of 5 stars Make an Appoinment Request More Information By completing this form, you agree to learn more about this study and see if you qualify. First Name:* Last Name:* Email Address:* Phone:* I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: YesNo
Trial Objective Researchers are studying the blood of hypersensitivity pneumonitis (HP) patients to find out if biomarkers found can predict the progression of the disease. Researchers are particularly interested in understanding if the biomarkers in blood can predict the speed of disease progression.